These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32727790)

  • 1. Mutant
    Nishi K; Ishikura S; Umebayashi M; Morisaki T; Inozume T; Kinugasa T; Aoki M; Nimura S; Swain A; Yoshida Y; Hasegawa S; Nabeshima K; Sakata T; Shirasawa S; Tsunoda T
    Anticancer Res; 2020 Aug; 40(8):4663-4674. PubMed ID: 32727790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Suppression of Human Colorectal Cancer Cells with Mutated
    Luo H; Nishi K; Ishikura S; Swain A; Morishige N; Yazaki R; Ohshima T; Shirasawa S; Tsunoda T
    Anticancer Res; 2018 Jul; 38(7):4247-4256. PubMed ID: 29970558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a Three-dimensional Floating Cell Culture System for Screening Drugs Targeting KRAS-mediated Signaling Molecules.
    Tsunoda T; Ishikura S; Doi K; Iwaihara Y; Hidesima H; Luo H; Hirose Y; Shirasawa S
    Anticancer Res; 2015 Aug; 35(8):4453-9. PubMed ID: 26168486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS.
    Nishi K; Tsunoda T; Uchida Y; Sueta T; Sawatsubashi M; Yamano T; Hashiguchi Y; Swain A; Shirasawa S; Sakata T
    Anticancer Res; 2020 Aug; 40(8):4687-4694. PubMed ID: 32727793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant
    Nishi K; Luo H; Ishikura S; Doi K; Iwaihara Y; Wills L; Baillie GS; Sakata T; Shirasawa S; Tsunoda T
    Anticancer Res; 2017 Jul; 37(7):3833-3839. PubMed ID: 28668883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products.
    Hashimoto S; Nagai M; Nishi K; Ishikura S; Nakabayashi K; Yazaki R; Ohshima T; Suenaga M; Shirasawa S; Tsunoda T
    Anticancer Res; 2021 Aug; 41(8):4061-4070. PubMed ID: 34281875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
    Courau T; Bonnereau J; Chicoteau J; Bottois H; Remark R; Assante Miranda L; Toubert A; Blery M; Aparicio T; Allez M; Le Bourhis L
    J Immunother Cancer; 2019 Mar; 7(1):74. PubMed ID: 30871626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
    Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor intrinsic and extrinsic immune functions of CD155.
    O'Donnell JS; Madore J; Li XY; Smyth MJ
    Semin Cancer Biol; 2020 Oct; 65():189-196. PubMed ID: 31883911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer.
    Freed-Pastor WA; Lambert LJ; Ely ZA; Pattada NB; Bhutkar A; Eng G; Mercer KL; Garcia AP; Lin L; Rideout WM; Hwang WL; Schenkel JM; Jaeger AM; Bronson RT; Westcott PMK; Hether TD; Divakar P; Reeves JW; Deshpande V; Delorey T; Phillips D; Yilmaz OH; Regev A; Jacks T
    Cancer Cell; 2021 Oct; 39(10):1342-1360.e14. PubMed ID: 34358448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD155T/TIGIT Signaling Regulates CD8
    He W; Zhang H; Han F; Chen X; Lin R; Wang W; Qiu H; Zhuang Z; Liao Q; Zhang W; Cai Q; Cui Y; Jiang W; Wang H; Ke Z
    Cancer Res; 2017 Nov; 77(22):6375-6388. PubMed ID: 28883004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer.
    Li S; Ding J; Wang Y; Wang X; Lv L
    J Gastroenterol Hepatol; 2022 Jan; 37(1):154-163. PubMed ID: 34734434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS
    Charitou T; Srihari S; Lynn MA; Jarboui MA; Fasterius E; Moldovan M; Shirasawa S; Tsunoda T; Ueffing M; Xie J; Xin J; Wang X; Proud CG; Boldt K; Al-Khalili Szigyarto C; Kolch W; Lynn DJ
    Br J Cancer; 2019 Jul; 121(1):37-50. PubMed ID: 31133691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras activation induces expression of Raet1 family NK receptor ligands.
    Liu XV; Ho SS; Tan JJ; Kamran N; Gasser S
    J Immunol; 2012 Aug; 189(4):1826-34. PubMed ID: 22798674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner.
    Yoshida K; Nishi K; Ishikura S; Nakabayashi K; Yazaki R; Ohshima T; Suenaga M; Shirasawa S; Tsunoda T
    Anticancer Res; 2022 Aug; 42(8):3993-4001. PubMed ID: 35896235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
    Triki H; Charfi S; Bouzidi L; Ben Kridis W; Daoud J; Chaabane K; Sellami-Boudawara T; Rebai A; Cherif B
    Life Sci; 2019 Aug; 231():116543. PubMed ID: 31176775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.
    Costa D; Venè R; Benelli R; Romairone E; Scabini S; Catellani S; Rebesco B; Mastracci L; Grillo F; Minghelli S; Loiacono F; Zocchi MR; Poggi A
    Front Immunol; 2018; 9():1150. PubMed ID: 29910806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer.
    Gharagozloo M; Kalantari H; Rezaei A; Maracy MR; Salehi M; Bahador A; Hassannejad N; Narimani M; Sanei MH; Bayat B; Ghazanfari H
    Bratisl Lek Listy; 2015; 116(5):296-301. PubMed ID: 25924638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.
    Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z
    Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells inhibit natural killer cells in myelodysplastic syndromes through the TIGIT/CD155 pathway.
    Yue J; Li J; Ma J; Zhai Y; Shen L; Zhang W; Li L; Fu R
    Hematology; 2023 Dec; 28(1):2166333. PubMed ID: 36651499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.